PRIMARY CUTANEOUS T-CELL LYMPHOMA
Clinical trials for PRIMARY CUTANEOUS T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY CUTANEOUS T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for PRIMARY CUTANEOUS T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough lymphoma: experimental drug ST-001 enters human testing
Disease control Recruiting nowThis early-phase trial tests a new drug called ST-001 (a form of fenretinide) in people with T-cell non-Hodgkin lymphoma whose cancer has returned or not responded to prior treatments. The main goal is to find the safest dose and understand side effects. About 46 participants wil…
Matched conditions: PRIMARY CUTANEOUS T-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: SciTech Development, Inc. • Aim: Disease control
Last updated May 25, 2026 01:28 UTC
-
Massive T-Cell lymphoma database aims to unlock better treatments
Knowledge-focused Recruiting nowThis study is creating a large database of information from 1,000 people with T-cell lymphoma. Researchers will collect medical records and tumor samples to learn more about the disease and how to improve care. No new treatments are being tested; the goal is to gather data for fu…
Matched conditions: PRIMARY CUTANEOUS T-CELL LYMPHOMA
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC